A RANDOMIZED TRIAL OF CISPLATIN (CACP) + 5-FLUOROURACIL (5-FU) INFUSION AND CACP + 5-FU BOLUS FOR RECURRENT AND ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK

被引：0
|
作者：
KISH, JA
ENSLEY, JF
JACOBS, J
WEAVER, A
CUMMINGS, G
ALSARRAF, M
机构：
[1] WAYNE STATE UNIV,HARPER GRACE HOSP,DIV ONCOL,DETROIT,MI 48201
[2] WAYNE STATE UNIV,HARPER GRACE HOSP,DEPT OTOLARYNGOL,DETROIT,MI 48201
[3] WAYNE STATE UNIV,HARPER GRACE HOSP,DEPT SURG,DETROIT,MI 48201
[4] VET ADM MED CTR,ALLEN PK,MI 48101
来源：
CANCER | 1985年 / 56卷 / 12期
关键词：
D O I：
10.1002/1097-0142(19851215)56:12<2740::AID-CNCR2820561203>3.0.CO;2-Y
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2740 / 2744
页数：5
相关论文
共 50 条
  • [31] Effect of 5-fluorouracil (5-FU) infusion in myocardial perfusion scans
    Bishiniotis, T
    Mouratidou, D
    Pentheroudakis, G
    Andreadis, C
    Katseas, G
    Litos, A
    Hatseras, D
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 60 - 60
  • [32] 5-FLUOROURACIL (5-FU) COMBINED WITH LEUCOVORIN (LV) IN PATIENTS WITH ADVANCED 5-FU RESISTANT COLORECTAL-CANCER
    VANGROENINGEN, CJ
    PETERS, GJ
    PINEDO, HM
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 202 - 202
  • [33] Continuous infusion of 5-fluorouracil (5-FU) in neuroendocrine tumours (NET)
    Ducreux, M
    Baudin, E
    Thabut, D
    Rougier, P
    Tigaud, JM
    Elias, D
    Boige, V
    Schlumberger, M
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S213 - S213
  • [34] PHASE-II TRIAL OF A COMBINATION OF LOW-DOSE CISPLATIN (DDP) AND BOLUS 5-FLUOROURACIL (FU) IN RECURRENT AND METASTATIC SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    COGNETTI, F
    CLERICO, M
    VERMORKEN, J
    VANRYMENANT, M
    ROSSI, A
    KIRKPATRICK, A
    DALESIC, O
    CLAVEL, M
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1986, 22 (07): : 891 - 892
  • [35] PHASE-II TRIAL WITH CARBOPLATIN/5-FU FOR PREVIOUSLY UNTREATED PATIENTS WITH ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    VOLLING, P
    SCHRODER, M
    RAUSCHNING, W
    ACHTERRATH, W
    STENNERT, E
    NAGEL, G
    HNO, 1988, 36 (11) : 452 - 455
  • [36] CLINICAL AND PHARMACOLOGICAL STUDIES OF 5-FLUOROURACIL (5-FU) ARTERIAL INFUSION FOR CARCINOMA IN THE LIVER
    SPICER, DV
    THIRLWELL, MP
    SITAR, DS
    HERBA, MJ
    MAKSYMIUK, AW
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 418 - 418
  • [37] Concurrent chemoradiotherapy with protracted infusion of 5-fluorouracil (5-FU) and cisplatin for locally advanced resectable esophageal cancer
    Almhanna, Khaldoun
    Hoffe, Sarah
    Strosberg, Jonathan
    Dinwoodie, William
    Meredith, Kenneth
    Shridhar, Ravi
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2015, 6 (01) : 39 - 44
  • [38] Protracted infusional 5-fluorouracil (5-FU) with bolus mitomycin in 5-FU-resistant colorectal cancer
    Chester, JD
    Dent, JT
    Wilson, G
    Ride, E
    Seymour, MT
    ANNALS OF ONCOLOGY, 2000, 11 (02) : 235 - 237
  • [39] Selective delivery of 5-fluorouracil (5-FU) to ip tissues using 5-FU microspheres in rats
    Hagiwara, A
    Sakakura, C
    Tsujimoto, H
    Imanishi, T
    Ohgaki, M
    Yamasaki, J
    Sawai, K
    Takahashi, T
    Fujita, T
    Yamamoto, A
    Muranishi, S
    Ikada, Y
    ANTI-CANCER DRUGS, 1997, 8 (02) : 182 - 188
  • [40] Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer
    Bleiberg, H
    Conroy, T
    Paillot, B
    Lacave, AJ
    Blijham, G
    Jacob, JH
    Bedenne, L
    Namer, M
    DeBesi, P
    Gay, F
    Collette, L
    Sahmoud, T
    EUROPEAN JOURNAL OF CANCER, 1997, 33 (08) : 1216 - 1220
12345